• Story Reviews
  • News Release Reviews
  • Blog
  • Podcasts
  • About Us
  • Toolkit for journalists and consumers
  • Contact
  • Newsletter Signup
HealthNewsReview.org HealthNewsReview.org HealthNewsReview.org
  • 2616 Story Reviews
  • 606 News Release Reviews
  • 2936 Blog Posts
  • Home
  • Story Reviews
  • News Release Reviews
  • Blog
  • Podcasts
  • About Us
    • Editorial Team
    • What We Review and How
    • Review Criteria
    • How Is the Star Score Determined?
    • Our Comments Policy
    • Accolades for HealthNewsReview.org
    • Talks, Workshops & Presentations
  • Toolkit
    • Tips for Analyzing Studies & Health Care Claims
    • Just for Journalists: Writing Tips
    • Stories of Patient Harm from Misleading Media
    • Pre-publication News Release Review
    • Health News Watchdog podcasts
    • News Sites & Blogs We Like
    • List of Industry-Independent Experts
    • Links to Other Resources
  • Contact

Search Results for "alzheimer's hype"

June 11, 2015 | News Release Review 1

Brain MRIs as a tool to prevent Alzheimer’s? Too much hype, and too little evidence, from a radiology society news release

This report strikes out on many levels and does many things that we think news releases shouldn’t do.

1 Star
AMERICAN SOCIETY OF NEURORADIOLOGY

Preventive neuroradiology: Brain imaging bolsters efforts to lower Alzheimer's risk

1
3/25/2015

CBS: slow down the Alzheimer’s drug trial hype – 2 examples in 1 week.

What follows are the third and fourth Alzheimer’s disease news items we’ve reviewed in the last 3 days.  This could be a full-time beat. Perhaps some of what we’re seeing was prompted by The Alzheimer’s Association conducting its “advocacy forum” in Washington this week, with a national fundraising dinner last night (with CNN’s Wolf Blitzer […]

9/4/2018

Podcast: The problematic promise of a ‘cure’ for Alzheimer’s disease

The Alzheimer’s Association has fundraising commercials promising breakthroughs and cures for a disease in which the cause is unknown and a treatment hasn’t been found. Is this irresponsible? Unethical? Potentially harmful?

1
7/27/2018

Many questions linger about this possible Alzheimer’s treatment. So why the avalanche of news coverage?

News organizations rightly reported the numerous asterisks attached to a small mid-stage study of a potential Alzheimer’s treatment highlighted at this week’s Alzheimer’s Association International Conference. As some stories reported, the study was a Phase 2 trial that hasn’t been peer reviewed or published in a journal, in which the drug didn’t meet its primary […]

July 25, 2018 | Story Review

HealthDay provides needed details on side effects of THC-based drug studied for Alzheimer’s agitation

However, the story didn’t provide any supporting numbers for the touted benefits.

4 Star
Health Day

Could Pot-Linked Drug Help Ease Agitation in Alzheimer's?

June 14, 2018 | News Release Review

No, an asthma drug tested in mice does not bring ‘new hope’ for Alzheimer’s patients, at least not yet

Use of use of words like “breakthrough” and a phrase suggesting the drug offers “new hope” for patients detract from the cautious aspects of this release.

1 Star
Temple University Health System

Temple researchers reverse cognitive impairments in mice with dementia

March 28, 2018 | News Release Review 2

‘Daily ibuprofen can prevent Alzheimer’s disease’ and other unproven claims by Canadian neuroscientist

The news release suggests that the way to diagnose Alzheimer’s disease early is by looking for elevated levels of Abeta42 in the saliva, thereby allowing early treatment with ibuprofen. However, no data on the accuracy of this screening method is included.

1 Star
IOS Press

Canadian neuroscientists say daily ibuprofen can prevent Alzheimer's disease

3/23/2018

‘$7.9 trillion’ savings from earlier Alzheimer’s diagnosis: Is there a hidden agenda behind the numbers?

More disease advocacy organizations are enlisting business consulting groups to conduct research to further their causes and, not coincidentally, those of their pharmaceutical company sponsors. This week the strategy paid off for the Alzheimer’s Association: An article in Bloomberg News headlined “Spotting Alzheimer’s Early Could Save America $7.9 Trillion” came from the annual Facts and […]

February 19, 2018 | Story Review

ABC downplays gloomy context in reporting ‘remarkable’ BACE1 finding for Alzheimer’s

This story buoyantly reports on a finding that amyloid plaque can be reversed in mice but misses potential harms and an announcement about an aborted BACE1 trial in humans just a day earlier.

1 Star
ABCNews.com

Alzheimer's disease reversed in mice, offering hope for humans, new research shows

3
Alzheimer's drug research
8/22/2017

5 questions to ask when writing (and reading) about new Alzheimer’s drug research

Now is a good time to prepare for the onslaught of public relations messages about new Alzheimer’s disease (AD) drugs that are coming down the pike. This fall, at least six phase III AD drug trials will be wrapping up–and it’s a sure bet their findings will be published in both major and minor journals […]

6/22/2017

Here’s why you can go ahead and ignore all those clickbaiting ‘olive oil protects against Alzheimer’s’ headlines

What a story from USA Today: “Extra virgin olive oil staves off Alzheimer’s, preserves memory, new study shows.” I’m not even sure where to begin on this one. So. Many. Issues. And, unfortunately, USA Today was not the only news outlet to cover this study. Newsweek, the Atlanta Journal-Constitution, and Philadelphia Inquirer all covered it, too. […]

August 3, 2016 | News Release Review

Company release on green tea for Down syndrome good on transparency, avoids hype

Trial sponsor is up-front about sponsorship and uses measured language in its news release.

3 Star
Life Extension

Life Extension-supported study published in Lancet Neurology finds green tea extract improves cognition in Down Syndrome

2
3/17/2016

Sensational Tweets on Alzheimer’s & breast cancer by University of Manchester in 1 week

Kathlyn Stone, an associate editor, manages our health care news release review project. She tweets at @KatKStone People who should know better are playing cat and mouse with health claims on Twitter. In the course of one week the University of Manchester used Twitter to promote two sensational health claims. Last week evolutionary biologist Jonathan […]

6
1/6/2016

Can $2 billion a year cure Alzheimer’s?

The following is a guest post by Linda Furlini, PhD, who works as a research associate at the Faculty of Dentistry, McGill University, in Montreal. Editor’s note: When Hillary Clinton’s campaign gathered reporters on a conference call recently to announce her plan to devote $2 billion annually to Alzheimer’s research that would lead to a […]

9/17/2015

Where does the hype come from? A news release/news story comparison

Hype in health news stories often originates with an exaggerated news release from an academic institution, research suggests. But news releases aren’t always to blame when journalists make over-the-top claims about a study. Sometimes, the news release can do an excellent job of presenting a careful, cautious summary of the research that emphasizes limitations and […]

  • 1
  • 2
  • 3
  • 4
  • Next »

Toolkit

Tips & Resources for Analyzing Health Care Claims

Surrogate markers may not tell the whole story

Screening: How overdiagnosis and other harms can undermine the benefits

A place to tell stories of patient harm from misleading media

View More

Toolkit

Institutional Home

University of Minnesota - School of Public Health
  • Home
  • Story Reviews
  • News Release Reviews
  • Blog
  • About Us
  • Toolkit
  • Contact

Copyright © 2021 HealthNewsReview.org